 8-APR-1987 16:40:07.16

CENTOCOR <CNTO> IN PACT WITH AJINOMOTO

Centocor Inc said it entered into an agreement with <Ajinomoto Co Inc> for the exclusive distribution of Centocor's Panorex in Japan.     Panorex is a monoclonal antibody, made through recombinant gene technology, for the treatment of pancreatic cancer. It has been tested in humans in Europe and the U.S. since 1982. Centocor said it intends to begin clinical trials in the U.S. this year with a modified form of the drug.     Under the agreement, Ajinomoto will conduct clinical tests of the drug in Japan and both companies will jointly file for marketing approval for the product in Japan.  Reuter &#3;

